Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Mach7 Technologies ( (AU:M7T) ) has shared an update.
Mach7 Technologies Limited has announced an update regarding its ongoing buy-back program, which involves the repurchase of its ordinary fully paid securities. As of the latest update, the company has bought back a total of 4,400,000 securities, including 80,000 on the previous day. This buy-back initiative is part of Mach7’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology sector, focusing on providing innovative solutions for healthcare imaging and data management. The company is known for its advanced software products that enhance the efficiency and effectiveness of medical imaging workflows, catering primarily to healthcare providers and institutions.
Average Trading Volume: 256,868
Technical Sentiment Signal: Sell
Current Market Cap: A$90.47M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.